Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity MA Knowles, CD Hurst Nature reviews cancer 15 (1), 25-41, 2015 | 1231 | 2015 |
Intragenic ERBB2 kinase mutations in tumours P Stephens, C Hunter, G Bignell, S Edkins, H Davies, J Teague, ... Nature 431 (7008), 525-526, 2004 | 943 | 2004 |
Bladder cancer O Sanli, J Dobruch, MA Knowles, M Burger, M Alemozaffar, ME Nielsen, ... Nature reviews Disease primers 3 (1), 1-19, 2017 | 816 | 2017 |
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ... Nature genetics 42 (11), 978-984, 2010 | 503 | 2010 |
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer LA Kiemeney, S Thorlacius, P Sulem, F Geller, KKH Aben, SN Stacey, ... Nature genetics 40 (11), 1307-1312, 2008 | 495 | 2008 |
IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors FE Bleeker, S Lamba, S Leenstra, D Troost, T Hulsebos, WP Vandertop, ... Human mutation 30 (1), 7-11, 2009 | 480 | 2009 |
Oncogenic FGFR3 gene fusions in bladder cancer SV Williams, CD Hurst, MA Knowles Human molecular genetics 22 (4), 795-803, 2013 | 433 | 2013 |
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma AH Jebar, CD Hurst, DC Tomlinson, C Johnston, CF Taylor, MA Knowles Oncogene 24 (33), 5218-5225, 2005 | 427 | 2005 |
Distinct microRNA alterations characterize high-and low-grade bladder cancer JWF Catto, S Miah, HC Owen, H Bryant, K Myers, E Dudziec, S Larré, ... Cancer research 69 (21), 8472-8481, 2009 | 399 | 2009 |
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer DC Tomlinson, O Baldo, P Harnden, MA Knowles The Journal of pathology 213 (1), 91-98, 2007 | 390 | 2007 |
Allelotype of human bladder cancer MA Knowles, PA Elder, M Williamson, JP Cairns, ME Shaw, MG Law Cancer research 54 (2), 531-538, 1994 | 370 | 1994 |
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer RE Banks, P Tirukonda, C Taylor, N Hornigold, D Astuti, D Cohen, ... Cancer research 66 (4), 2000-2011, 2006 | 350 | 2006 |
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? MA Knowles Carcinogenesis 27 (3), 361-373, 2006 | 344 | 2006 |
A germline deletion of p14ARF but not CDKN2A in a melanoma–neural system tumour syndrome family JA Randerson-Moor, M Harland, S Williams, D Cuthbert-Heavens, ... Human molecular genetics 10 (1), 55-62, 2001 | 323 | 2001 |
Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer FM Platt, CD Hurst, CF Taylor, WM Gregory, P Harnden, MA Knowles Clinical cancer research 15 (19), 6008-6017, 2009 | 301 | 2009 |
What is cancer LM Franks, MA Knowles Introduction to the cellular and molecular biology of cancer 4, 4-9, 2005 | 295* | 2005 |
Proteomic changes in renal cancer and co‐ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect RD Unwin, RA Craven, P Harnden, S Hanrahan, N Totty, M Knowles, ... PROTEOMICS: International Edition 3 (8), 1620-1632, 2003 | 291 | 2003 |
DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene JL Kissil, E Feinstein, O Cohen, PA Jones, YC Tsai, MA Knowles, ... Oncogene 15 (4), 403-407, 1997 | 276 | 1997 |
Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. P Cairns, ME Shaw, MA Knowles Oncogene 8 (4), 1083-1085, 1993 | 272 | 1993 |
Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency CD Hurst, O Alder, FM Platt, A Droop, LF Stead, JE Burns, GJ Burghel, ... Cancer cell 32 (5), 701-715. e7, 2017 | 267 | 2017 |